Skip to content

Imaging Genetics Study of Thought Disorder in Schizophrenia

Imaging Genetics Study of Thought Disorder in Schizophrenia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112605
Enrollment
Unknown
Registered
2025-11-17
Start date
2025-07-09
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

formal thought disorder in schizophrenia

Interventions

FTD Group:None

Sponsors

Wuxi Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Inclusion Criteria for the FTD Group: (1) Both biological parents are Han Chinese; (2) Right-handed; (3) Age 18-60 years, no gender restriction; (4) Meets the clinical diagnostic criteria for schizophrenia according to DSM-5; (5) Thought, Language, and Communication scale (TLC) score > 0; (6) Obtain the patient’s written informed consent; if the patient is incapable of providing consent during the illness, written informed consent must be obtained from their legal guardian. 2. Inclusion Criteria for the HC Group: (1) Both biological parents are Han Chinese; (2) Age 16-60 years, no gender restriction; (3) Previously mentally stable and currently does not meet the clinical diagnostic criteria for any DSM-5 entry; (4) Has not received antipsychotic treatment; (5) Obtain their written informed consent.

Exclusion criteria

Exclusion criteria: 1. Exclusion criteria for the FTD group: (1) Individuals meeting DSM-5 diagnostic criteria for schizoaffective disorder, mood disorders, developmental delay, pervasive developmental disorder, delirium, dementia, memory disorder, or other cognitive disorders; (2) Patients with severe and unstable physical illnesses (e.g., heart disease); (3) Narrow-angle glaucoma; (4) Individuals with a history of epilepsy, except for febrile seizures; (5) Patients meeting DSM-5 diagnostic criteria for substance dependence; (6) Those who have or have had neuroleptic malignant syndrome; (7) Individuals unable to take medication as prescribed or without a caregiver; (8) Pregnant or breastfeeding women, or those planning pregnancy; (9) Those with contraindications for MRI scanning. 2. Exclusion criteria for the HC group: (1) Individuals meeting DSM-5 diagnostic criteria for schizophrenia, schizoaffective disorder, mood disorders, developmental delay, pervasive developmental disorder, delirium, dementia, memory disorder, or other cognitive disorders; (2) Patients with severe and unstable physical illnesses (e.g., heart disease); (3) Narrow-angle glaucoma; (4) Individuals with a history of epilepsy, except for febrile seizures; (5) Patients meeting DSM-5 diagnostic criteria for substance dependence; (6) Those who have or have had neuroleptic malignant syndrome; (7) Individuals unable to take medication as prescribed or without a caregiver; (8) Pregnant or breastfeeding women, or those planning pregnancy; (9) Those with contraindications for MRI scanning.

Design outcomes

Primary

MeasureTime frame
cortical thickness;sulcal depth;gray matter volume;

Countries

China

Contacts

Public ContactYu Xia

Wuxi Mental Health Center

1260031189@qq.com+86 15195080910

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026